CFTR and COVID-19: In particular, our GEN-COVID consortium has previously shown that the individuals carrying single pathogenic variants of the CFTR gene, i.e., CF-carriers, were more likely to undergo severe COVID-19, with a higher risk of 14-day mortality [17] and their geographical distribution correlated with COVID-19 spread and fatalities in 37 countries [18].